When looking for a place to grow a life sciences business over the long term, sometimes the biggest location isn't ...

Clean, humanized data and data systems are the crucial fuel for engines driving new AI capabilities and uses across the ...

The FDA's new FAQ on cell and gene therapy offers a roadmap for developers. Review key insights from the document, including ...

Francois is chairman of the board at Acceleron Pharma. He is the former CEO of NPS Pharmaceuticals and serves on several other corporate and philanthropy boards.

Aron Knickerbocker leverages his Big Pharma credentials to launch successful biotech startups, including his most recent venture, Aulos, which uses AI to accelerate drug development.

Since 2008, PCM Trials has led the way in mobile research. Our Certified Mobile Research Nurses (CMRNs) are driving the shift to patient-centric, decentralized clinical trials, giving individuals the ...

"A version of this article was published first on Hyman, Phelps & McNamara’s FDA Law Blog. It is republished here with permission." In November, President-Elect Trump announced his pick of Robert ...

Woody Bryan, Ph.D. has founded several biotech companies during his career, and he explains how his journey from scientist to business development prepared him for the C-suite.

Life Biosciences' Jerry McLaughlin and Forge Biologics' John Maslowski explain the importance of transparency and collaboration when encountering manufacturing speed bumps.

Biopharma guru Allan Shaw speculates on the risks and benefits that the incoming Trump administration could bring to the industry.